We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Caffeine for Apnea of Prematurity (CAP)
Updated: 3/20/2018
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants
Status: Enrolling
Updated: 3/20/2018
Caffeine for Apnea of Prematurity (CAP)
Updated: 3/20/2018
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants
Status: Enrolling
Updated: 3/20/2018
Click here to add this to my saved trials
ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
Updated: 3/21/2018
ADDRESS - Multicenter, Partially-randomized Controlled Trial of Adult Deformity Robotic vs. Freehand Surgery to Correct Adult Spine Deformity
Status: Enrolling
Updated: 3/21/2018
ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
Updated: 3/21/2018
ADDRESS - Multicenter, Partially-randomized Controlled Trial of Adult Deformity Robotic vs. Freehand Surgery to Correct Adult Spine Deformity
Status: Enrolling
Updated: 3/21/2018
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Updated: 3/22/2018
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Click here to add this to my saved trials
Surface Stimulation for Female Sexual Dysfunction
Updated: 3/22/2018
Surface Stimulation for Female Sexual Dysfunction
Status: Enrolling
Updated: 3/22/2018
Surface Stimulation for Female Sexual Dysfunction
Updated: 3/22/2018
Surface Stimulation for Female Sexual Dysfunction
Status: Enrolling
Updated: 3/22/2018
Click here to add this to my saved trials
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
Updated: 3/23/2018
Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents
Status: Enrolling
Updated: 3/23/2018
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
Updated: 3/23/2018
Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials
Click here to add this to my saved trials
Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
Updated: 3/27/2018
A Multicenter, 6-week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of NFC-1 in Adolescents (Ages 12-17) With Genetic Disorders Impacting Metabotropic Glutamate Receptors and ADHD
Status: Enrolling
Updated: 3/27/2018
Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
Updated: 3/27/2018
A Multicenter, 6-week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of NFC-1 in Adolescents (Ages 12-17) With Genetic Disorders Impacting Metabotropic Glutamate Receptors and ADHD
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Updated: 3/27/2018
Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Status: Enrolling
Updated: 3/27/2018
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Updated: 3/27/2018
Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Updated: 3/28/2018
HLA-mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High Risk Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/28/2018
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Updated: 3/28/2018
HLA-mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High Risk Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials
Group vs. Traditional Diabetes Prenatal Care
Updated: 3/28/2018
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated: 3/28/2018
Group vs. Traditional Diabetes Prenatal Care
Updated: 3/28/2018
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials
Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
Updated: 3/29/2018
Insulin and the Polycystic Ovary Syndrome
Status: Enrolling
Updated: 3/29/2018
Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
Updated: 3/29/2018
Insulin and the Polycystic Ovary Syndrome
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Veress Entry With/Without Concomitant CO2
Updated: 3/29/2018
Laparoscopic Entry Technique With a Veress Needle Insertion With and Without Concomitant CO2 Insufflation - Does it Matter?
Status: Enrolling
Updated: 3/29/2018
Veress Entry With/Without Concomitant CO2
Updated: 3/29/2018
Laparoscopic Entry Technique With a Veress Needle Insertion With and Without Concomitant CO2 Insufflation - Does it Matter?
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Updated: 3/30/2018
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Status: Enrolling
Updated: 3/30/2018
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Updated: 3/30/2018
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Updated: 4/3/2018
Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia
Status: Enrolling
Updated: 4/3/2018
Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Updated: 4/3/2018
Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Updated: 4/3/2018
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Updated: 4/3/2018
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Updated: 4/3/2018
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Updated: 4/3/2018
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
ToRsemide for pOstpartum HYpertension
Updated: 4/3/2018
Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial
Status: Enrolling
Updated: 4/3/2018
ToRsemide for pOstpartum HYpertension
Updated: 4/3/2018
Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Studies of Heritable Disorders of Connective Tissue
Updated: 4/4/2018
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated: 4/4/2018
Studies of Heritable Disorders of Connective Tissue
Updated: 4/4/2018
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
Updated: 4/4/2018
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Updated: 4/4/2018
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
Updated: 4/4/2018
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
Updated: 4/4/2018
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
Updated: 4/4/2018
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
Updated: 4/4/2018
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Human Sperm Binding to Transgenic Mouse Eggs
Updated: 4/4/2018
Human Sperm Binding to Transgenic Mouse Eggs
Status: Enrolling
Updated: 4/4/2018
Human Sperm Binding to Transgenic Mouse Eggs
Updated: 4/4/2018
Human Sperm Binding to Transgenic Mouse Eggs
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
Updated: 4/4/2018
HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project)
Status: Enrolling
Updated: 4/4/2018
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
Updated: 4/4/2018
HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project)
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Updated: 4/4/2018
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Updated: 4/4/2018
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Updated: 4/5/2018
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials